Spyre Therapeutics Inc (SYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,430 | 85,645 | 22,461 | 14,532 | 20,579 |
| Marketable Securities | 80,111 | 38,070 | 52,052 | 50,203 | 51,614 |
| Receivables | N/A | N/A | N/A | 2,422 | 4,281 |
| TOTAL | $109,935 | $126,818 | $76,671 | $70,382 | $78,888 |
| Non-Current Assets | |||||
| PPE Net | 921 | 952 | 1,018 | 846 | 776 |
| Other Non-Current Assets | 6,638 | 749 | 50 | 49 | 49 |
| TOTAL | $7,559 | $1,701 | $1,068 | $895 | $825 |
| Total Assets | $117,494 | $128,519 | $77,739 | $71,277 | $79,713 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,724 | 3,223 | 663 | 1,077 | 952 |
| Accrued Expenses | 9,967 | 8,266 | 9,576 | 6,438 | 5,223 |
| TOTAL | $13,019 | $11,806 | $10,239 | $7,515 | $6,175 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,860 | 424 | 72 | 81 | 91 |
| TOTAL | $4,860 | $424 | $72 | $81 | $91 |
| Total Liabilities | $17,879 | $12,230 | $10,311 | $7,596 | $6,266 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,155 | 1,154 | 1,153 | 958 | 880 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | -152,047 | -134,028 | -116,861 | -101,963 | -90,046 |
| Other shareholders' equity | 67 | 13 | -27 | -33 | -56 |
| TOTAL | $99,615 | $116,289 | $67,428 | $63,681 | $73,447 |
| Total Liabilities And Equity | $117,494 | $128,519 | $77,739 | $71,277 | $79,713 |